← Back to Search

Intraocular Lens

Model SC9 for Cataract

N/A
Waitlist Available
Research Sponsored by CORD, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new eye lens called Model SC9 to see if it helps people see better up close and at middle distances compared to a standard lens. It involves patients who need lens implants and will follow them for several years.

Eligible Conditions
  • Cataract
  • Pseudoaphakia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Improvement in Visual Acuity Measurements using the LogMar Scale
Secondary study objectives
Defocus testing in 0.5D increments from -0.5 to -5.00D

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Model SC9Experimental Treatment1 Intervention
Investigational IOL
Group II: Model LI61SEActive Control1 Intervention
FDA Approved IOL

Find a Location

Who is running the clinical trial?

CORD, LLCLead Sponsor
J Stuart Cumming, M.D.Study ChairCORD, LLC
John Hovanesian, M.D.Study ChairCORD, LLC
2 Previous Clinical Trials
448 Total Patients Enrolled
~40 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top